BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25109118)

  • 1. Double-hit primary unilateral adrenal lymphoma with good outcome.
    Marković O; Marisavljević D; Jelić S; Mihaljević B; Martinović T; Cemerikić V
    Vojnosanit Pregl; 2014 Jul; 71(7):689-92. PubMed ID: 25109118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Green TM; Young KH; Visco C; Xu-Monette ZY; Orazi A; Go RS; Nielsen O; Gadeberg OV; Mourits-Andersen T; Frederiksen M; Pedersen LM; Møller MB
    J Clin Oncol; 2012 Oct; 30(28):3460-7. PubMed ID: 22665537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary adrenal non-Hodgkin's lymphoma: report of two cases.
    Ezer A; Parlakgümüş A; Kocer NE; Colakoğlu T; Nursal GN; Yildirim S
    Turk J Gastroenterol; 2011 Dec; 22(6):643-7. PubMed ID: 22287414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and treatment outcomes of non-Hodgkin's lymphomas involving rare extranodal sites: a single-center experience.
    Yun J; Kim SJ; Kim JA; Kong JH; Lee SH; Kim K; Ko YH; Kim WS
    Acta Haematol; 2010; 123(1):48-54. PubMed ID: 19955711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Adrenal Lymphoma: Two Case Series From China.
    Zeng J; Yan F; Chen Y; Zang L; Chen K; Lyu Z; Dou J; Mu Y; Lin M; Yang G
    Front Endocrinol (Lausanne); 2021; 12():778984. PubMed ID: 35154000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Hodgkin's lymphoma involving a femur bone and bilateral adrenal glands alone with adrenal insufficiency.
    Iwahara Y; Shinohara T; Naruse K; Komatsu Y
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28143809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
    Landsburg DJ; Falkiewicz MK; Petrich AM; Chu BA; Behdad A; Li S; Medeiros LJ; Cassaday RD; Reddy NM; Bast MA; Vose JM; Kruczek KR; Smith SE; Patel P; Hernandez-Ilizaliturri F; Karmali R; Rajguru S; Yang DT; Maly JJ; Blum KA; Zhao W; Vanslambrouck C; Nabhan C
    Br J Haematol; 2016 Nov; 175(4):631-640. PubMed ID: 27469075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients.
    Koh YW; Hwang HS; Park CS; Yoon DH; Suh C; Huh J
    Leuk Lymphoma; 2015; 56(9):2630-6. PubMed ID: 25573205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary malignant lymphoma of the adrenal gland: a case report].
    Mizusawa H; Okaneya T; Yoneyama T; Taguchi I
    Hinyokika Kiyo; 1995 Dec; 41(12):991-4. PubMed ID: 8578989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary adrenal non-Hodgkin lymphoma: a case report and review of the literature.
    Ram N; Rashid O; Farooq S; Ulhaq I; Islam N
    J Med Case Rep; 2017 Apr; 11(1):108. PubMed ID: 28410600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary bilateral adrenal lymphoma revealed by hemophagocytic syndrome.
    Alaoua A; Gilbert G; Ghannouchi N; Houchlef M; Letaief A; Bahri F
    Ann Endocrinol (Paris); 2011 Jun; 72(3):247-50. PubMed ID: 21640976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
    Wang C; Li W; Liu C; He H; Bai O
    Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases.
    Li X; Shen W; Cao J; Wang J; Chen F; Wang C; Zou S; Shen B; Zhao R; Li J; Shen Z
    Ann Hematol; 2012 Nov; 91(11):1721-9. PubMed ID: 22733613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effective combined modality therapy for a patient with primary adrenal lymphoma].
    Shirao S; Kuroda H; Kida M; Watanabe H; Matsunaga T; Niitsu Y; Konuma Y; Hirayama Y; Kohda K
    Rinsho Ketsueki; 2006 Mar; 47(3):204-9. PubMed ID: 16629485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
    Akyurek N; Uner A; Benekli M; Barista I
    Cancer; 2012 Sep; 118(17):4173-83. PubMed ID: 22213394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary bilateral adrenal non-Hodgkin's Burkitt-like lymphoma: a rare cause of primary adrenal insufficiency. Case report and literature review.
    Dobrinja C; Trevisan G; Liguori G
    Tumori; 2007; 93(6):625-30. PubMed ID: 18338503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary ovarian lymphoma--a rare entity.
    Afshan A; Sadaf N
    J Pak Med Assoc; 2013 Apr; 63(4):519-20. PubMed ID: 23905454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.
    Molina TJ; Canioni D; Copie-Bergman C; Recher C; Brière J; Haioun C; Berger F; Fermé C; Copin MC; Casasnovas O; Thieblemont C; Petrella T; Leroy K; Salles G; Fabiani B; Morschauser F; Mounier N; Coiffier B; Jardin F; Gaulard P; Jais JP; Tilly H
    J Clin Oncol; 2014 Dec; 32(35):3996-4003. PubMed ID: 25385729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
    Yhim HY; Kim JS; Kang HJ; Kim SJ; Kim WS; Choi CW; Eom HS; Kim JA; Lee JH; Won JH; Shim H; Huh J; Lee DH; Suh C; Kwak JY
    Int J Cancer; 2012 Jul; 131(1):235-43. PubMed ID: 21823120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases.
    Zhou D; Xie WZ; Hu KY; Huang WJ; Wei GQ; He JS; Shi JM; Luo Y; Li L; Zhu JJ; Zhang J; Lin MF; Ye XJ; Cai Z; Huang H
    Asian Pac J Cancer Prev; 2013; 14(2):929-34. PubMed ID: 23621263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.